Journal of Clinical Pediatrics ›› 2021, Vol. 39 ›› Issue (12): 938-.doi: 10.3969/j.issn.1000-3606.2021.12.013

Previous Articles     Next Articles

Anti-N-methyl-D-aspartate-receptor encephalitis with rhabdomyolysis in children

HOU Chi, LI Xiaojing, TIAN Yang, ZENG Yiru, ZHU Haixia, ZHANG Yani, ZHENG Kelu, LIAO Yinting, PENG Bingwei, LIANG Huici, GAO Yuanyuan, CHEN Wenxiong   

  1. Guangzhou Women and Children's Medical Center, Guangzhou 510120 , Guangdong, China
  • Published:2021-12-22

Abstract: To explore the clinical features and prognosis of children with anti-N-methyl-D-aspartatereceptor (NMDAR) encephalitis complicated with rhabdomyolysis (RM). Methods The clinical data of 4 children with anti-NMDAR encephalitis complicated with RM were retrospectively analyzed. Results There were 3 boys and 1 girl with an average onset age of ( 9 . 3 ±4 . 3 ) years. The median time between onset symptom and diagnosis of anti-NMDAR encephalitis was 14 ( 10 - 20 ) days, and the median time between onset symptom and development of RM was 29 ( 22 - 40 ) days. The causes of RM included infection and status epilepticus ( 3 cases), and persistent involuntary movement ( 1 case). One patient recovered well after receiving steroid and intravenous immunoglobulin treatment and hydration and alkalization therapy. The other 3 patients with complicated infection and status epilepticus had poor response to the treatment and received plasma exchange and continuous hemofiltration. One died of septic shock, and 2 received rituximab treatment. One recovered well, while the other one had severe neurological sequelae. Conclusion Children with anti-NMDAR encephalitis can be complicated with RM. Patients in critical condition may have poor response to first-line immunotherapy and hydration and alkalization therapy, and blood purification therapy should be initiated in time.

Key words: anti-N-methyl-D-aspartate-receptor encephalitis; rhabdomyolysis; child